Specifically, expression of miR-34a, miR-182-5p and miR-338, miRNAs which regulate LMTK1 and LMTK3 production, is altered in Alzheimer’s disease, ALS/FTD and Huntington’s disease patients [134–147]. Here, AATK is linked to early-onset autosomal dominant Alzheimer disease.